Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel

M. T. Holmberg, A. Tornio, Mikko Sakari Neuvonen, P. J. Neuvonen, J. T. Backman, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume95
Issue number3
Pages (from-to)307-313
Number of pages7
ISSN0009-9236
DOIs
Publication statusPublished - Mar 2014
MoE publication typeA1 Journal article-refereed

Fields of Science

  • IMPLEMENTATION CONSORTIUM GUIDELINES
  • ACUTE CORONARY SYNDROMES
  • PLASMA-CONCENTRATIONS
  • CYP2C19 GENOTYPE
  • HEALTHY-SUBJECTS
  • MAJOR DETERMINANT
  • ORAL AVAILABILITY
  • GENETIC-VARIANTS
  • CYTOCHROMES P450
  • CITRUS JUICES
  • 3111 Biomedicine

Cite this

@article{5cc7774c9964430d89ef38182913cf4e,
title = "Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel",
keywords = "IMPLEMENTATION CONSORTIUM GUIDELINES, ACUTE CORONARY SYNDROMES, PLASMA-CONCENTRATIONS, CYP2C19 GENOTYPE, HEALTHY-SUBJECTS, MAJOR DETERMINANT, ORAL AVAILABILITY, GENETIC-VARIANTS, CYTOCHROMES P450, CITRUS JUICES, 3111 Biomedicine",
author = "Holmberg, {M. T.} and A. Tornio and Neuvonen, {Mikko Sakari} and Neuvonen, {P. J.} and Backman, {J. T.} and Mikko Niemi",
year = "2014",
month = "3",
doi = "10.1038/clpt.2013.192",
language = "English",
volume = "95",
pages = "307--313",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "3",

}

Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel. / Holmberg, M. T.; Tornio, A.; Neuvonen, Mikko Sakari; Neuvonen, P. J.; Backman, J. T.; Niemi, Mikko.

In: Clinical Pharmacology and Therapeutics, Vol. 95, No. 3, 03.2014, p. 307-313.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel

AU - Holmberg, M. T.

AU - Tornio, A.

AU - Neuvonen, Mikko Sakari

AU - Neuvonen, P. J.

AU - Backman, J. T.

AU - Niemi, Mikko

PY - 2014/3

Y1 - 2014/3

KW - IMPLEMENTATION CONSORTIUM GUIDELINES

KW - ACUTE CORONARY SYNDROMES

KW - PLASMA-CONCENTRATIONS

KW - CYP2C19 GENOTYPE

KW - HEALTHY-SUBJECTS

KW - MAJOR DETERMINANT

KW - ORAL AVAILABILITY

KW - GENETIC-VARIANTS

KW - CYTOCHROMES P450

KW - CITRUS JUICES

KW - 3111 Biomedicine

U2 - 10.1038/clpt.2013.192

DO - 10.1038/clpt.2013.192

M3 - Article

VL - 95

SP - 307

EP - 313

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -